Registry of patients with pacemakers and defibrillators

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a prospective registry of patients who are undergoing the implantation, replacement, or upgrade of pacemakers, implantable cardioverter defibrillators, or implanted loop recorders. It will enroll consecutive patients and follow them over the long term to document clinical events in a non-selected population. The study will focus on gathering data to better understand the outcomes and experiences of these patients post-implantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All consecutive patients underwent PM/ICD/ILR implantation
* Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent
* Patient must be able to attend all required follow-up visits at the study center for at least 12 months

Exclusion Criteria:

* No informed consent
* Patient is participating in another clinical study that may have an impact on the study endpoint

Exclusion Criteria:

* No informed consent

Where it's running

• Vincenzo Russo
  Naples, Napoli, Italy Recruiting

Study contacts

• Study coordinator: Vincenzo Russo, MD PhD
• Email: vincenzo.russo@unicampania.it
• Phone: +390817062355

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lead-related tricuspid valve leakage after first-time pacemaker or ICD implantation

  This project will see if a new transvenous pacemaker or ICD lead causes new or worse tricuspid valve regurgitation in people getting their first device.

  Recruiting Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW · Bad Oeynhausen, North Rhine-Westphalia · NCT07342036

• 3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation

  This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07793916

• Higher pacemaker rate for people with cardiac amyloidosis

  This study will see if temporarily increasing the pacemaker rate improves heart-failure symptoms and exercise tolerance in adults with cardiac amyloidosis who already have pacemakers.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07583823

• Left bundle branch pacing plus ICD for people with hypertrophic cardiomyopathy after myectomy

  This study will test whether adding left bundle branch pacing to a dual‑chamber ICD helps people with hypertrophic cardiomyopathy who develop left bundle branch block after myectomy to slow heart failure progression and prevent life‑threatening arrhythmias.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk, Novosibirsk Oblast · NCT07372196

• Leadless pacemaker outcomes and follow-up at University Hospital St. Pölten

  This registry will collect and analyze outcomes and complications in adults who receive leadless pacemakers at University Hospital St. Pölten to see how the devices perform over time.

  Recruiting Karl Landsteiner University of Health Sciences · Sankt Pölten, Lower Austria · NCT07246135

• Left bundle branch area pacing versus conventional right‑ventricular pacing after TAVI for atrioventricular block

  This will test whether left bundle branch area pacing works better than standard right‑ventricular pacing for people who need a pacemaker after TAVI.

  Recruiting at 6 sites Nantes University Hospital · Brest, Finistère and 6 other locations · NCT07236489

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.